These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 3178517)

  • 1. [Morphological characteristics of hyperuricemic variant of chronic latent glomerulonephritis].
    Pal'tsev MA; Varshavskii VA; Maksimov NA; Balkarov IM
    Arkh Patol; 1988; 50(6):8-15. PubMed ID: 3178517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Immune complex hyperuricemic nephritis: aspects of its morphology and pathogenesis].
    Maksimov NA; Varshavskiĭ VA; Balkarov IM; Pal'tsev MA; Poliantseva LR
    Ter Arkh; 1986; 58(8):97-101. PubMed ID: 2945281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hyperuricemic variant of latent glomerulonephritis].
    Mukhin NA; Serov VV; Maksimov NA; Balkarov IM; Varshavskiĭ BA
    Ter Arkh; 1985; 57(6):43-6. PubMed ID: 4071411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The clinico-morphological characteristics of psoriatic nephropathy].
    Panasiuk NN; Mukhin NA; Varshavskiĭ VA; Maksimov NA; Nikolaev AIu; Poliantseva LR; Balkarov IM; Golov KG; Antonov MV; Aleksandrovskaia TN
    Ter Arkh; 1990; 62(6):99-103. PubMed ID: 2218939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Chronic nephritis and hyperuricemia].
    Tofuku Y; Tanaka H; Sato T; Kuroda M
    Nihon Jinzo Gakkai Shi; 1974 Jul; 16(7):695-704. PubMed ID: 4478702
    [No Abstract]   [Full Text] [Related]  

  • 6. Transforming growth factor-beta receptors in self-limited vs. chronic progressive nephritis in rats.
    Watanabe T; Yamamoto T; Ikegaya N; Fujigaki Y; Suzuki H; Togawa A; Fukasawa H; Nagase M; Hishida A
    J Pathol; 2002 Nov; 198(3):397-406. PubMed ID: 12375273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The dependence of the progression of chronic glomerulonephritis on the clinical and morphological types of glomerulonephritis and on the tubulointerstitial changes].
    Ratner MIa; Fedorova ND
    Urol Nefrol (Mosk); 1998; (2):22-4. PubMed ID: 9577698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinico-morphological characteristics and prognosis of glomerulonephritis in chronic alcoholism].
    Nikolaev AIu; Serov VV; Tareeva IE; Varshavskiĭ VA; Lebedev SP
    Ter Arkh; 1986; 58(8):115-20. PubMed ID: 3764753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Uric acid correlates with the severity of histopathological parameters in IgA nephropathy.
    Myllymäki J; Honkanen T; Syrjänen J; Helin H; Rantala I; Pasternack A; Mustonen J
    Nephrol Dial Transplant; 2005 Jan; 20(1):89-95. PubMed ID: 15572382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Sclerotic changes in the glomeruli in glomerulonephritis in children (immunohistochemical study].
    Shekhonin BV; Gozalishvili TV; Varshavskiĭ VA
    Arkh Patol; 1995; 57(3):57-61. PubMed ID: 7677584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hereditary nephritis mimicking immune complex-mediated glomerulonephritis.
    Nasr SH; Markowitz GS; Goldstein CS; Fildes RD; D'Agati VD
    Hum Pathol; 2006 May; 37(5):547-54. PubMed ID: 16647952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The sialoadhesin (CD169) expressing a macrophage subset in human proliferative glomerulonephritis.
    Ikezumi Y; Suzuki T; Hayafuji S; Okubo S; Nikolic-Paterson DJ; Kawachi H; Shimizu F; Uchiyama M
    Nephrol Dial Transplant; 2005 Dec; 20(12):2704-13. PubMed ID: 16169862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Beta 2-microglobulin in the blood serum and urine of patients with interstitial kidney lesions].
    Golovanova OE; Reznikov IuP; Maksimov NA; Pankrat'ev LM; Balkarov IM
    Ter Arkh; 1986; 58(8):27-9. PubMed ID: 3532409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hereditary nephropathy associated with hyperuricemia and gout.
    Puig JG; Miranda ME; Mateos FA; Picazo ML; Jiménez ML; Calvin TS; Gil AA
    Arch Intern Med; 1993 Feb; 153(3):357-65. PubMed ID: 8427538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hyperuricemia as a risk factor of nephropathy in gout].
    Siniachenko OV; Diadyk AI; Nikolenko IuI; Vasilenko IV
    Ter Arkh; 1988; 60(1):97-101. PubMed ID: 3363519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histopathological changes and tumour necrosis factor-alpha, transforming growth factor-beta and tenascin expression in patients with primary type I membranoproliferative glomerulonephritis in remission.
    Arikan H; Koc M; Cakalagaoglu F; Tuglular S; Ozener C; Akoglu E
    Nephrology (Carlton); 2009 Apr; 14(2):219-26. PubMed ID: 19298642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Mesangial glomerulonephritis and intermediate uveitis].
    Román E; Zamora I; Vera F
    Nefrologia; 2004; 24(5):489-92. PubMed ID: 15648908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Diabetic glomerulonephritis--the first stage of diabetic glomerulopathy].
    Severgina ES; Ponomarev AB; Diuzheva TG; Shestakova MV; Maĭorova EM
    Arkh Patol; 1994; 56(4):44-50. PubMed ID: 7848105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mesangial proliferative glomerulonephritis in chronic obstructive pulmonary disease.
    Dasgupta DJ; Garg ID; Kaushal SS; Chauhan S; Sharma A; Goyal A
    J Indian Med Assoc; 1998 Nov; 96(11):338-40. PubMed ID: 10218320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibody-induced redistribution of Heymann antigen on the surface of cultured glomerular visceral epithelial cells: possible role in the pathogenesis of Heymann glomerulonephritis.
    Camussi G; Brentjens JR; Noble B; Kerjaschki D; Malavasi F; Roholt OA; Farquhar MG; Andres G
    J Immunol; 1985 Oct; 135(4):2409-16. PubMed ID: 3875653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.